SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002558
Filing Date
2019-04-25
Accepted
2019-04-25 09:01:05
Documents
10
Period of Report
2019-06-11
Effectiveness Date
2019-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238470zdef14a.htm DEF 14A 314114
2 G700527.JPG g700527.jpg GRAPHIC 4723
3 G323172.JPG g323172.jpg GRAPHIC 748
4 G577227.JPG g577227.jpg GRAPHIC 802
5 G728609.JPG g728609.jpg GRAPHIC 755
6 G171131.JPG g171131.jpg GRAPHIC 3949
7 G198114.JPG g198114.jpg GRAPHIC 3272
8 G603824.JPG g603824.jpg GRAPHIC 3928
9 G25952BGI001.GIF g25952bgi001.gif GRAPHIC 74032
10 G25952BGI002.GIF g25952bgi002.gif GRAPHIC 34133
  Complete submission text file 0001047469-19-002558.txt   490468
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37526 | Film No.: 19765567
SIC: 2834 Pharmaceutical Preparations